United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of “Moderate Buy” by Brokerages
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the company. The […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the company. The […]
